SDMA (p-hydroxyazobenzene-p′-sulfonate)
Product Specifications
CAS Number
1266235-58-8
Target
Endogenous Metabolite, NF-κB, NO Synthase
Related Pathways
NF-κB, Metabolism, Immunology/Inflammation
Bioactivity
SDMA p-Hydroxyazobenzene-p′-sulfonate is the p-hydroxyazobenzene-p′-sulfonate form of SDMA. It acts as an inhibitor of endogenous nitric oxide synthase (NO synthase) and serves as an activator of NF-κB, enhancing the expression of IL-6 and TNF-α. This compound remains stable in serum and plasma, making it a potential biomarker for liver and kidney dysfunction.
Smiles
OC(C=C1)=CC=C1N=NC2=CC=C(C=C2)S(=O)(O)=O.OC([C@@H](N)CCC/N=C(NC)/NC)=O.OC(C=C3)=CC=C3N=NC4=CC=C(C=C4)S(=O)(O)=O
Molecular Formula
C12H10N2O4S 1/2C8H18N4O2
Molecular Weight
379.4
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1144163-01 0.02 mg (E-Coli)
Recombinant Chlamydia trachomatis tRNA modification GTPase MnmE (mnmE)
Sign In for Pricing
View Details MBS1144163-02 0.02 mg (Yeast)
Recombinant Chlamydia trachomatis tRNA modification GTPase MnmE (mnmE)
Sign In for Pricing
View Details